Related Experiment Videos
p21--negative regulator of the cell cycle
A L Gartel1, M S Serfas, A L Tyner
1Department of Genetics, University of Illinois College of Medicine, Chicago 60607, USA.
Summary
The cell cycle regulator p21 (also known as WAF1, CIP1, SDI1, and MDA-6) is crucial for cell cycle arrest and tumor suppression. Despite appearing redundant in normal conditions, p21 holds potential for gene therapy applications.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Cell cycle progression is controlled by cyclins and cyclin-dependent kinases (Cdks).
- The cyclin kinase inhibitor p21 (WAF1, CIP1, SDI1, MDA-6) regulates cell cycle entry into S phase.
- p21 forms complexes with cyclin, Cdk, and PCNA in normal cells.
Purpose of the Study:
- To review the functional characterization of the cell cycle regulator p21.
- To explore the role of p21 in cell cycle control and potential therapeutic applications.
Main Methods:
- Literature review of studies on p21 function.
- Analysis of p21's role in cell cycle arrest and tumor suppression.
- Investigation of p21 gene transcription mechanisms (p53-dependent and -independent).
Main Results:
- p21 induces G1 arrest by inhibiting Cdks or PCNA.
- p21-deficient mice show no apparent phenotype, suggesting functional redundancy.
- p21 is expressed in terminally differentiating cells independently of p53.
- Overexpression of p21 suppresses tumor growth in vitro and in vivo.
Conclusions:
- p21 plays a critical role in cell cycle regulation, particularly in G1 arrest.
- While its function may seem redundant in normal cells, p21 is essential for p53-mediated arrest.
- p21 demonstrates significant potential for gene therapy in cancer treatment.